<DOC>
<DOCNO>
EP-0002902
</DOCNO>
<TEXT>
<DATE>
19790711
</DATE>
<IPC-CLASSIFICATIONS>
A61P-25/00 C07D-409/04 C07D-409/00 A61K-31/4427 A61K-31/445 A61K-31/4433 
</IPC-CLASSIFICATIONS>
<TITLE>
methylthiofluorothioxanthene derivative, its preparation and compositions containing it.
</TITLE>
<APPLICANT>
kefalas asdk<sep>kefalas a/s<sep>kefalas a/s7-9 ottiliavejdk-2500 copenhagen-valbydk<sep>
</APPLICANT>
<INVENTOR>
bogeso klaus peterdk<sep>bogeso, klaus peter<sep>bogeso, klaus peter15, molleaaparkendk-2800 kgs. lyngbydk<sep>
</INVENTOR>
<ABSTRACT>
the compound 2-methylthio-6-fluoro-9(1-methyl-4-piperidylidene)-thioxanthene  of the formula:    and its non-toxic acid addition salts have been shown in  animal experiment to possess very strong and longlasting  neuroleptic properties and at the same time, a low degree  of undesired side effects such as extrapyrimidal side effects.   they also have a low acute toxicity which makes the therapeutic  index favourable.  moreover, they have strong anticholinergic effects.  the compound may conveniently be prepared by  dehydrating 82-methylthio-6-fluoro-9-(1-methyl-4-piperidylidene)-thioxanthen-o1-9  of the formula:    by conventional means.  the compound of formula i and its acid addition salts  may be administered in the form of tablets, capsules,  powders, syrups, suppositories or solutions for injection.  
</ABSTRACT>
</TEXT>
</DOC>
